Insider · CIK 0001923343
Alan Perry Baden
Files at MIND (MIND TECHNOLOGY, INC). First filing -, latest -.
In brief
Alan Perry Baden files SEC Form 4 as director at MIND (MIND TECHNOLOGY, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alan Perry Baden has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | MIND MIND TECHNOLOGY, INC | AGrant or award Option to Purchase Common Stockderivative | +30,000 | $4.77 | $143k | 30,000 | Jul 31, 2026 |
| Oct 6, 2025 | MIND MIND TECHNOLOGY, INC | AGrant or award Option to Purchase Common Stockderivative | +30,000 | $8.64 | $259k | 30,000 | Oct 8, 2025 |
| Jan 20, 2025 | MIND MIND TECHNOLOGY, INC | AGrant or award Option to Purchase Common Stockderivative | +20,000 | $7.47 | $149k | 20,000 | Jan 22, 2025 |
Questions about Alan Perry Baden
Answered from the filings on this page, as of the latest one.
Is Alan Perry Baden buying or selling?
Alan Perry Baden has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alan Perry Baden's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alan Perry Baden has 0.
Where does Alan Perry Baden file Form 4?
Alan Perry Baden has filed Form 4 at MIND (MIND TECHNOLOGY, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.